Cargando…

Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals

BACKGROUND: The first line anti-tuberculosis drugs isoniazid (INH), rifampicin (RIF) and pyrazinamide (PZA) continues to be the effective drugs in the treatment of tuberculosis, however, the use of these drugs is associated with toxic reactions in tissues, particularly in the liver, leading to hepat...

Descripción completa

Detalles Bibliográficos
Autores principales: Eminzade, Sude, Uras, Fikriye, Izzettin, Fikret V
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491620/
https://www.ncbi.nlm.nih.gov/pubmed/18601745
http://dx.doi.org/10.1186/1743-7075-5-18